FCCC LOGO Faculty Publications
Khanna V , Panyam J , Griffith TS
Exploiting antibody biology for the treatment of cancer
Immunotherapy. 2020 Mar;12(4) :255-267
Back to previous list
Over the last decade, antibodies have become an important component in the arsenal of cancer therapeutics. High-specificity, low off-target effects, desirable pharmacokinetics and high success rate are a few of the many attributes that make antibodies amenable for development as drugs. To design antibodies for successful clinical applications, however, it is critical to have an understanding of their structure, functions, mechanisms of action and pharmacokinetic/pharmacodynamic properties. This review highlights some of these key aspects, as well as certain limitations encountered, with monoclonal antibody therapy. Further, we discuss rational combination therapies for clinical applications, some of which could help overcome the limitations.
1750-7448 Khanna, Vidhi Panyam, Jayanth Griffith, Thomas S Journal Article Review England Immunotherapy. 2020 Mar;12(4):255-267. doi: 10.2217/imt-2019-0118. Epub 2020 Mar 24.